Anthony Fauci celebrates the results of AstraZeneca’s evacuation test and is determined not to register security concerns

Anthony Fauci, the most important expert in governing diseases of the United States, celebrating these months the results of the new study in the country of the vacancy against the COVID-19 developed by Oxford / AstraZeneca, The case shows an efficiency of 79 per cent before the automatic cases of illness and one 100 per cent protection against serious cases.

“The good news is that it has a comparable efficiency in all ethnicities and editions, so it is a very good efficiency, 79.9 per cent, in participants who are 65 years older or more”, dijo Fauci during the information session of the response team at COVID-19 of the Casa Blanca.

The results of the investigation into what was going on in the territory of the European Union have been confirmed by the European Union’s regulatory agency. n jarretel during some days on its application. The security body of the United States has the same conclusion.

Respectfully, we also director of the National Institute of Allergy and Infected Diseases that “The vacancy was well tolerated and the June of Data and Security Monitoring did not identify specific security concerns related to the vehicles ”.

It is also known that the vacuum cleaner can be heated to the normal temperature of the refrigerator for at least six months. facilitates the distribution process.

The clinical trial involved 32,449 people from all demographic groups in the United States, Chile and Peru. In total there will be 141 COVID-19 cases.

Following the data collected on the site, the vaccine was well tolerated between the participants and the Independent Security Supervision Organization (DSMB) no identification “preoccupations” related to the security of the prepared.

The DSMB also found that there was no increase in the risk of suffering from thrombosis episodes among the 21,583 participants who received at least one dose of the vaccine.

Professor of Medicine at the University of Rochester (United States) Ann Falsey, coauthor del ensayo, afirmó hoy que “these hallelujahs vuelven have confirmed results observed in English of all adult populations but are illusory ver results of similar effects and mayors of 65 years for the first time ”.

“This analysis validates the AstraZeneca vaccine as an additional vaccination option, which offers security that adults of all ages can benefit from protection against the virus,” he said.

For his part, the Professor of Infection and Pediatric Medicine Andrew Pollard, head of the investigating officer del ensayo de la Oxford University, oorwaar que estos hallazgos son “grandes noticias” y “muestran la notable eficacia de la vacuna en una nuva poblacion y son consistentes des la results de los enayos ledare par Oxford”.

“We will experience a strong impact against COVID-19 in all groups of editions and in different origins of a generalized use of the window”, aggregate.

One of the creators of the vacuna, Sarah Gilbert, although the new halls “proportionally have more confirmation of their safety and effectiveness”.

“In many different countries and in all groups of expeditions -excus-, the vaccine is proportional to a high level of protection against covid-19 and we believe that there is a greater use of the vaccine in global intentions to give a fin to the pandemic ”.

AstraZeneca will update the dates on the Food and Pharmacy Administration of the United States (FDA) and will look for the emergence approval for its use.

SEGUIR LEYENDO: